Diosmin

CHEMBL231884 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

608.5 g/mol

LogP

-0.8

Phase

4

A flavonoid glycoside found naturally in certain plants, used to treat chronic venous insufficiency and hemorrhoids by strengthening and reducing the permeability of blood vessel walls and improving lymphatic drainage. It is often combined with hesperidin in standardized preparations. It is widely used in Europe for leg heaviness, swelling, and varicose veins.

Berat Molekul

608,5000 g/mol

LogP

-0,80

TPSA

234,00 Å²

Lipinski RO5

Gagal

Area Terapeutik

Infectious Disease Respiratory Disease Rheumatoid Arthritis Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Gastroesophageal Reflux Disease Inflammatory Bowel Disease Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Deep Vein Thrombosis / Pulmonary Embolism Breast Cancer Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O

InChI

InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1

Molecular Formula

C28H32O15

HBD / HBA

8 / 15

Ikatan yang Dapat Dirotasi

7

Atom Berat

43

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A flavonoid glycoside found naturally in certain plants, used to treat chronic venous insufficiency and hemorrhoids by strengthening and reducing the permeability of blood vessel walls and improving lymphatic drainage. It is often combined with hesperidin in standardized preparations. It is widely used in Europe for leg heaviness, swelling, and varicose veins.

Yes, Diosmin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL231884. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5281613. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Diosmin di PillFYI

Struktur

Data Cepat

Rumus: C28H32O15
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.